Screening of serum biomarkers for coronary artery calcification using DIA quantitative proteomics and construction of a regression model - Takeaways - MDSpire

Screening of serum biomarkers for coronary artery calcification using DIA quantitative proteomics and construction of a regression model

  • By

  • Ruyan Cui

  • Xiaoyu Liu

  • June 1, 2026

  • 0 min

Share

  • 1

    The study identifies SMOC1, HSP90B1, and OPTN as potential serum biomarkers for coronary artery calcification (CAC) using DIA quantitative proteomics.

  • 2

    A two-stage case-control design involved 320 patients, with 160 in the CAC group and 160 in the non-calcified control group.

  • 3

    The logistic regression model incorporating biomarkers and clinical indicators achieved an AUC of 0.894, outperforming traditional models.

  • 4

    Differentially expressed proteins were enriched in pathways related to protein folding, immune signaling, and apoptosis regulation.

  • 5

    The nomogram model demonstrated good calibration and positive clinical net benefit, indicating its effectiveness in predicting CAC.

Original Source(s)

Related Content